AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study NCT04518033 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Various commercially available face coverings
Description: Various commercially available face coverings
Study NCT05724641 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: EXPERIMENTAL
Intervention: MRI perfusion imaging using ASL's non-invasive technique
Description: Patients will undergo through an MRI-scan using the ASL MRI sequence, as described per protocol.
Study NCT05101343 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Breathing meditation
Description: Daily, 5-minute breathing meditation for one week.
Study NCT05503576 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: reminder mobile application
Description: After thyroidectomy, patients will be reminded of medication and control appointments. In addition, patients will be able to access up-to-date and short trainings.
Study NCT05419791 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Robot Asisted Gait Training with Lokomat (Endurance)
Description: * Faster application (using for Endurance) : 3 days in a week for 6 weeks,very season was 40 min.~* Conventional Physiotherapy : 5 days in a week for 6 weeks, every seanson was 40 min.
Study NCT05419791 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Robot Asisted Gait Training with Lokomat (Attention and Motivation)
Description: * Smile application (using for Attetion and Motivation) : 3 days in a week for 6 weeks,very season was 20 min.~* Gabarello application (using for Attetion and Motivation) : 3 days in a week for 6 weeks,very season was 20 min.~* Conventional Physiotherapy : 5 days in a week for 6 weeks, every seanson was 40 min.
Study NCT05419791 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Robot Asisted Gait Training with Lokomat (Activity Timing)
Description: * High Flyer application (using for Activity Timing) : 3 days in a week for 6 weeks,very season was 20 min.~* Treasures application (using for Activity Timing) : 3 days in a week for 6 weeks,very season was 10 min.~* Curve Pursuit application (using for Activity Timing) : 3 days in a week for 6 weeks,very season was 10 min.~* Conventional Physiotherapy : 5 days in a week for 6 weeks, every seanson was 40 min.
Study NCT05419791 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: Conventional Physiotherapy
Description: -Conventional Physiotherapy : 5 days in a week for 6 weeks, every seanson was 40 min.
Study NCT05419791 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Conventional Physiotherapy
Description: -Conventional Physiotherapy : 5 days in a week for 6 weeks, every seanson was 40 min.
Study NCT04770844 — intervention group
Intervention type: OTHER
Intervention: Acquisitions
Description: Three acquisitions of 1 hours during hospitalization will be realized:~* a few days after hospitalization,~* in the middle of the hospitalization,~* a few days before hospital discharge. The child will be lying on his back in a heated cradle and filmed with a specific camera. The signal will be obtained by 2k ZED 2 stereo camera in order to obtain a three-dimensional location of the child
Study NCT04919096 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: SCB-420
Description: Subjects randomised to SCB-420 arm will receive a total of 3 doses of SCB-420 as an intravitreal injection of 2 mg into the study eye every 4 weeks on Day 1, Week 4, and Week 8.
Study NCT04919096 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Aflibercept
Description: Subjects randomised to Aflibercept arm will receive a total of 3 doses of Aflibercept as an intravitreal injection of 2 mg into the study eye every 4 weeks on Day 1, Week 4, and Week 8.
Study NCT05875493 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: JAB-21822
Description: 2 discrete single doses
Study NCT06128746 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Repetitive Transcranial Magnetic Stimulation
Description: 1 Hz rTMS treatment for 20 mins, follow by 30 mins intensive limb training
Study NCT06128746 — intervention group
Intervention type: DEVICE
Group type: SHAM_COMPARATOR
Intervention: Sham Repetitive Transcranial Magnetic Stimulation
Description: Sham Hz rTMS treatment for 20 mins, follow by 30 mins intensive limb training
Study NCT05230485 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: CPAP level
Description: The level of continuous distending pressure (or positive end-expiratory pressure) chosen on CPAP
Study NCT05230485 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: CPAP level
Description: The level of continuous distending pressure (or positive end-expiratory pressure) chosen on CPAP
Study NCT05648565 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Radiofrequency ablation (RFA)
Description: The NEUROMARK device is an in-office, disposable bipolar RFA device with a treatment tip consisting of micro electrodes which delivers RF energy while monitoring appropriate tissue contact to maximize delivery to posterior nasal nerve and its variable branching. After topical anesthesia consisting of oxymetazoline and 1% lido followed by 4% lidocaine, the device will be placed in the posterior inferior turbinate under endoscopic visualization. The device will be activated per manufacturer's instructions
Study NCT06151743 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: three cycles (toripalimab + cetuximab + platinum)
Description: Cetuximab 250 mg/m2 i.v. qw (first loading dose 400 mg/m2) for nine doses; Toripalimab 240 mg/m2 i.v. d1, q21d, three cycles; Cisplatin 25 mg/m2 i.v. d1-3, q21d, three cycles or Carboplatin AUC 5 i.v. d1, q21d, three cycles (patients with cisplatin contraindications or renal impairment after cisplatin use).
Study NCT06151743 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Radical surgery
Description: The attending physician should select the appropriate surgical treatment and try to perform radical laryngeal preservation surgery for patients with tumor retraction after induction therapy. Patients who cannot preserve laryngeal function due to tumor load need to undergo total laryngeal resection. According to the scope of pharyngectomy, the surgical treatments include partial laryngopharyngectomy, total laryngectomy and partial pharyngectomy, total laryngopharyngectomy, and total pharyngo-laryngo-esophagectomy. Cervical lymph node dissection was performed when necessary.
Study NCT06151743 — intervention group
Intervention type: RADIATION
Group type: EXPERIMENTAL
Intervention: Radiotherapy or chemoradiotherapy
Description: 1. Using intensity-modulated radiotherapy (IMRT) technology, the dose of radiotherapy is determined according to whether there are adverse prognostic factors in the postoperative pathology, including positive margins, extracapsular invasion of lymph nodes, primary pT3 or T4, N2 lymph node lesions, peripheral nerve invasion, vascular/lymphatic infiltration.~   Primary site: residual GTV or tumor bed dose 60-70Gy: 1.8-2.12 Gy / fraction. Cervical lymph nodes or lymphatic drainage area: 56-70 Gy: 1.7-2.12 Gy / fraction.~2. Postoperative adjuvant concurrent chemotherapy regimen:~Cisplatin 25mg/m2 i.v. d1-3, d22-24 or Carboplatin AUC 5 i.v. d1, d22 (if cisplatin contraindications).
Study NCT05041920 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: famitinib、omeprazole
Description: famitinib malate, 25 mg on study day 1; omeprazole, 40 mg, qd on study day 10-14, 16-22; famotine malate together with omeprazole, on study day 15.
Study NCT05503056 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: art therapy
Description: six sessions of art therapy with licensed therapists
Study NCT05503056 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: nothing
Description: no intervention to this group
Study NCT05940818 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: the intensive oral care
Description: the intensive oral care
Study NCT05906355 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: the wearable filtrating artificial Kidney Device
Description: the wearable filtrating artificial kidney device rapidly for rapid relief of fluid overload in patients
Study NCT05906355 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: traditional hemodialysis machine
Description: the hemodialysis machine currently used in clinical practice to reduce fluid overload in patients
Study NCT06425185 — intervention group
Intervention type: OTHER
Intervention: Single-leg stance under different instability conditions
Description: Participants will perform three attempts of 20 seconds of single-leg stance on the floor and on the 7 selected configurations of the BB. The order of measurement will be randomized. The description of the chosen configurations can be found in the Detailed Description section. In all cases, the participant's objective is to ensure that the edges of the BB are not in contact with the floor.~The position of the participant on the BB will be a single-leg stance on the randomly chosen foot, with the contralateral knee slightly flexed and hands placed on the hips. Participants will look at a fixed point placed 3 meters in front of them.~A rest period of 30 seconds will be allowed between trials. The physiotherapist responsible for supervising the measurements will be the one to adjust the BB configurations when needed.
Study NCT05818202 — intervention group
Intervention type: OTHER
Intervention: Questionannire
Description: The questionannaires for both physiotherapists and stroke patients were formed in this study. The perspectives of the participants were recorded.
Study NCT02856295 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: clexane (LMWH)
Description: to compare tow doses of clexane for preventing VTE in postpartum women
Study NCT04305158 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Nitrous Oxide
Description: Patient receiving nitrous oxide are evaluated for success of the procedure
Study NCT04305158 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Nitrous Oxide
Description: Patient receiving nitrous oxide are evaluated for success of the procedure
Study NCT04998058 — intervention group
Intervention type: PROCEDURE
Group type: PLACEBO_COMPARATOR
Intervention: Maxillary sinus floor elevation grafting with synthetic bone substitute.
Description: Bone augmentation at the floor of the maxillary sinus with bone substitutes.
Study NCT04998058 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Maxillary sinus floor elevation grafting with synthetic bone substitute.
Description: Bone augmentation at the floor of the maxillary sinus with bone substitutes.
Study NCT05132777 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: JMT101
Description: JMT101, 6 mg/kg, IV infusion once every two weeks (one treatment cycle is 4 weeks).
Study NCT05132777 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Osimertinib Mesylate Tablets
Description: Osimertinib, 160 mg, Oral administration once daily (one treatment cycle is 4 weeks).
Study NCT05613244 — intervention group
Intervention type: OTHER
Intervention: Phone call
Description: Patients will be asked to complete a questionnaire via a phone call
Study NCT05007236 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: RP7214 + Standard of care (SOC)
Description: RP7214 tablets will be administered orally twice a day for 14 days
Study NCT05007236 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo + Standard of care (SOC)
Description: Placebo will be administered orally twice a for 14 days
Study NCT06348992 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Acceptance commitment therapy and yoga
Description: The intervention used a combination of online and offline methods, based on ACT, supplemented by hatha yoga exercise intervention, the intervention group used the combination of offline ACT psychological intervention and online hatha yoga training, and the control group used mental health education, so as to explore and validate the effect of ACT combined with yoga on the improvement of parental parental burnout in children with ASD. The offline ACT psychological intervention was implemented by the researchers and psychologists, and the ACT psychological intervention was carried out once a week in community health centers or hospitals for 8 weeks. Online, a WeChat group was set up for parents with ASD, and Hatha Yoga training content and videos were sent to the group chat, and the researchers and volunteers supervised the training and clocking in and out of the group, three times a week.
Study NCT06348992 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Active Comparator: Mental Health Education Group
Description: The control group was provided with 8 weeks of mental health education, including emotional management skills, positive coping styles, and scientific parenting methods.
Study NCT06006676 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Near Apnoeic ventilation
Description: Near Apnoeic ventilation (with a respiratory rate of 2 breaths per minute, plateau pressure of 30cmH20 and PEEP set according to the mean airway pressure being delivered during mechanical ventilation prior to randomisation) for a 72 hour period following randomisation
Study NCT06006676 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Crossover standardised ECMO weaning trials
Description: When all patients are eligible for a trial of ECMO weaning, they will have standardised ECMO weaning trials lasting up to 1 hour with 0 sweep gas flow. 1) One-stage weaning- sweep gas flow rate sequentially decreased to zero 2) Two-stage weaning- fraction of oxygen of sweep gas flow decreased to 0.21 sequentially. Then the sweep gas flow rate decreased to 0 sequentially
Study NCT06006676 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Crossover standardised ECMO weaning trials
Description: When all patients are eligible for a trial of ECMO weaning, they will have standardised ECMO weaning trials lasting up to 1 hour with 0 sweep gas flow. 1) One-stage weaning- sweep gas flow rate sequentially decreased to zero 2) Two-stage weaning- fraction of oxygen of sweep gas flow decreased to 0.21 sequentially. Then the sweep gas flow rate decreased to 0 sequentially
Study NCT06303232 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: MANUAL LYMPHATIC DRAINAGE
Description: MLD was performed after the moist heating of 10 minutes in supine position with both knees bent. It will start from the abdominal lymph drainage followed by the central lymph drainage.~Then, by stimulating the bilateral axillary lymph nodes, the flow of the fluid was directed to the axillary lymph node. Each session lasted for approximately 45 minutes, for 7 days
Study NCT06303232 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: THERAPEUTIC ULTRASOUND
Description: The participants of group B will receive a treatment of manual lymphatic drainage and ultrasound after the moist heat of 10 minutes. After MLD of 45 minutes, ultrasound will be performed in small circular pattern from periphery to the center towards the areola with following parameters: Mode: pulsed, Frequency: 1MHz, Intensity: 1W/cm2, Time: 8 minutes. Treatment was given for 7 consecutive days
Study NCT05989958 — intervention group
Intervention type: COMBINATION_PRODUCT
Group type: EXPERIMENTAL
Intervention: HepaCure
Description: HepaCure will be administered in extracorporal dialysis for single dose or multiple doses with different treatment duration on top of DPMAS.
Study NCT06564896 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: CPAP Airsense 10 vs Air-Mini
Description: Patients' satisfaction and CPAP efficacy
Study NCT04886700 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: SG001
Description: Subjects will receive intravenous infusion of SG001 at the dose of 240 mg every 2 weeks until disease progression, unacceptable toxicity, meeting the suspension or termination criteria, or up to 24 months in patients without disease progression.
Study NCT04809259 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Isothermal pouch
Description: The study will verify it the use of an isothermal pouch to maintain the content of an elastomeric pump at 10° to 15°C avoids unacceptable meropenem degradation over the 24 hour infusion period.
Study NCT06315738 — intervention group
Intervention type: BIOLOGICAL
Group type: OTHER
Intervention: ST266
Description: Patients randomized to investigative drug product (ST266) will receive either 0.5 mL/kg or 1.0 mL/kg of ST266 QD in addition to Standard of Care treatment; Patients randomized to SOC will receive standard of care treatment only.
Study NCT06298201 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: E-Based Physical Exercise Intervention
Description: The intervention comprises a 6-months home-based resistance training for the lower extremities, conducted twice weekly.
Study NCT04803955 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: 16mg，KB
Description: 16mg,Q8h±3min,Day1-Day7
Study NCT04803955 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebos
Description: 16mg,Q8h±3min,Day1-Day7
Study NCT06583915 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: TENS
Description: Non-pharmacological method which is widely used by medical and paramedical professionals for the management of acute and chronic pain using electric pulse generator, lead wires and electrodes.
Study NCT06583915 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Dry Needle
Description: Invasive procedure where a fine needle or acupuncture needle is inserted into the skin and muscle.
Study NCT06426914 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Clinical Pilates
Description: Warmup: 5-10 minutes Pilates Clinical (Introductory program) The Hundred modified The Roll-up modified The roll-over modified Spine twist modified Single-leg circle modified Rolling like a ball Shoulder Bridge modified~For every Step emphasizing:~FOCUS: On muscle involved REPETITIONS: 3-5 VISUALIZATION: Imagination process (Different for each step) Cool down: 5 minutes Total Time: 30 minutes
Study NCT06426914 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Cardiac Rehabilitation
Description: Chest Physical therapy (Chest percussions and active huffs as per need) Breathing strategies (Diaphragmatic and purse lip 1-3 sets \* 5 Reps/Day)~Functional mobility (walk /cycling as per patient tolerance)~Patient education and Wound care Sternal Precaution guidance
Study NCT05044195 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: aQIV
Description: Participants receive a 0.5-mL intramuscular dose of aQIV on Day 1
Study NCT05044195 — intervention group
Intervention type: BIOLOGICAL
Group type: ACTIVE_COMPARATOR
Intervention: Comparator QIV
Description: Participants receive a 0.5-mL intramuscular dose of Comparator QIV on Day 1
Study NCT04822207 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: acupuncture
Description: Patients undergo acupuncture at the beginning of embryo transfer cycle three times a week until 14 days after embryo transfer. Every acupuncture lasts 20 minutes.
Study NCT05986617 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: InBody Band 2
Description: Wearable bioimpediance monitor similar to a fitness watch.
Study NCT04730427 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: GX-I7
Description: Recombinant human interleukin-7 hybrid Fc
Study NCT04730427 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: GX-I7 vehicle
Description: Formulation buffer of recombinant human interleukin-7 hybrid Fc
Study NCT06146582 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Laguna Coach and App Intervention Group
Description: Behavioral, mental and contextual support was delivered through personal interactions with Laguna Coaches via mobile app, phone, video, or web chat. Care interventions were individualized to best match each participant's needs and strengths. Support will be provided to participants through interactions over approximately 90 days.
Study NCT06522399 — intervention group
Intervention type: PROCEDURE
Intervention: TAMIS mucosectomy
Description: internal Delorme's procedure using TAMIS
Study NCT04033601 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Non-pharmacological intervention
Description: The non-pharmacological intervention will comprise sleep hygiene education, exercise training and relevant modules of cognitive behavioral therapy.
Study NCT06218407 — intervention group
Intervention type: COMBINATION_PRODUCT
Group type: EXPERIMENTAL
Intervention: Computerized Chemosensory-Based Orbitofrontal Cortex Training (CBOT) short burst paradigm
Description: The CBOT device is designed to stimulate intensive neural activity in the medial orbitofrontal regions over long periods of time.
Study NCT06218407 — intervention group
Intervention type: COMBINATION_PRODUCT
Group type: EXPERIMENTAL
Intervention: Computerized Chemosensory-Based Orbitofrontal Cortex Training (CBOT) long burst paradigm
Description: The CBOT device is designed to stimulate intensive neural activity in the lateral orbitofrontal regions and networks over long periods of time.
Study NCT06218407 — intervention group
Intervention type: COMBINATION_PRODUCT
Group type: EXPERIMENTAL
Intervention: Computerized Chemosensory-Based Orbitofrontal Cortex Training plus beta caryophyllene (CBOT-Plus)
Description: CBOT device enhanced with BCP.
Study NCT06218407 — intervention group
Intervention type: COMBINATION_PRODUCT
Group type: SHAM_COMPARATOR
Intervention: Computerized Chemosensory-Based Orbitofrontal Cortex Training (CBOT)
Description: CBOT device administering continuous olfactory stimuli (i.e., not programmed for short or long burst), and without BCP enhancement.
Study NCT03463954 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Novilase Laser ablation
Description: Image-guided, percutaneous laser ablation of breast tumors
Study NCT06079151 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Nasal high-flow
Description: Nasal high-flow is a respiratory technique which allows the administration of warmed and humidified air, associated with oxygen if necessary
Study NCT05184933 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: At-home Polysomnography
Description: Participants will complete one night of unattended polysomnography in their home environment (SOMNOtouch RESP, SOMNOmedics America Inc., FL, USA).